Peter D Haytaian
CIK 1608538 · EVP & Pres Carelon & CarelonRx · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.81M
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$67.44M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | EVP & Pres Carelon & CarelonRx | 24,803 | $385.73 | $9.57M | -$10.55M | 7 | 2026-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Pres., DBG & IngenioRx | 13,441 | $482.58 | $6.49M | -$56.89M | 28 | 2022-03-14 |
| ANTX | EVP & President, GBD | 52,653 | $4.70 | $247.5K | $0 | 10 | 2018-03-05 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Pres., Govt. Bus. Div. | 45,037 | — | — | $0 | 1 | 2014-12-03 |
Recent Filings · Page 2 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-03 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +1,167 | $0 | EDGAR |
| 2021-05-07 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −1,000 | -$270.0K | EDGAR |
| 2021-03-23 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −21,407 | -$15.52M | EDGAR |
| 2021-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +11,309 | -$4.59M | EDGAR |
| 2020-12-17 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$965.9K | EDGAR |
| 2020-11-18 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −4,126 | -$1.73M | EDGAR |
| 2020-10-19 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −1,167 | -$1.23M | EDGAR |
| 2020-10-13 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −1,167 | -$344.3K | EDGAR |
| 2020-10-06 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$860.0K | EDGAR |
| 2020-06-10 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −2,580 | -$3.16M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.